Statement of Cash Flows—Indirect Method

The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows:

		Dec. 31, 20Y3		Dec. 31, 20Y2
Assets
Cash		$261,120		$243,460
Accounts receivable (net)		94,590		87,440
Inventories		267,040		258,890
Investments		0		100,300
Land		136,970		0
Equipment		294,620		228,890
Accumulated depreciation—equipment		(68,980)		(61,720)
	Total assets	$985,360		$857,260
Liabilities and Stockholders' Equity
Accounts payable (merchandise creditors)		$178,350		$168,880
Accrued expenses payable (operating expenses)		17,740		22,290
Dividends payable		9,850		7,720
Common stock, $10 par		53,210		42,010
Paid-in capital: Excess of issue price over par-common stock		200,030		116,590
Retained earnings		526,180		499,770
	Total liabilities and stockholders’ equity	$985,360		$857,260

Additional data obtained from an examination of the accounts in the ledger for 20Y3 are as follows:

1. The investments were sold for $117,350 cash.
2. Equipment and land were acquired for cash.
3. There were no disposals of equipment during the year.
4. The common stock was issued for cash.
5. There was a $66,700 credit to Retained Earnings for net income.
6. There was a $40,290 debit to Retained Earnings for cash dividends declared.

Required:

Prepare a statement of cash flows, using the indirect method of presenting cash flows from operating activities. Use the minus sign to indicate cash out flows, cash payments, decreases in cash, or any negative adjustments.

Livers Inc.
Statement of Cash Flows
For the Year Ended December 31, 20Y3
Cash flows from operating activities:
	$
Adjustments to reconcile net income to net cash flow from operating activities:
Changes in current operating assets and liabilities:
Net cash flow from operating activities		$
Cash flows from investing activities:
	$
Net cash flow used for investing activities
Cash flows from financing activities:
	$
Net cash flow from financing activities
		$
Cash at the beginning of the year
Cash at the end of the year		$